Scientists test new way to treat eczema
Researchers at Vanderbilt University Medical Center have developed a new investigational drug that can block inflammatory signaling in a preclinical model of atopic dermatitis—eczema.
Jan 12, 2023
0
10
Researchers at Vanderbilt University Medical Center have developed a new investigational drug that can block inflammatory signaling in a preclinical model of atopic dermatitis—eczema.
Jan 12, 2023
0
10
New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found no clear association between immunosuppressive or anti-fibrotic medications and worsening gastrointestinal ...
Nov 8, 2022
0
2
People with autoimmune or auto-inflammatory rheumatic diseases have an increased risk of infections. This can be due to the underlying disease itself, or may be caused by treatment with immunomodulating or immunosuppressive ...
Oct 28, 2022
0
15
Receiving a medical diagnosis can be difficult. You may only hear parts of the conversation as you start to think about what treatment will be needed and how this will affect your daily life. It can be especially challenging ...
Oct 17, 2022
0
15
Researchers at Baylor College of Medicine and collaborating institutions have engineered immune cells to control two major life-threatening complications, namely graft-vs-host disease (GvHD) and cancer relapse, which typically ...
Sep 27, 2022
0
15
Fear of becoming severely ill with COVID-19 caused high rates of stress and anxiety during lockdown in people who had pancreas or islet transplants to treat type 1 diabetes, reveals new research being presented at the annual ...
Sep 14, 2022
0
7
Kidney transplant recipients (KTRs) have experienced severe symptoms and poor outcomes with COVID-19. Because the long-term antirejection immunosuppressive drugs that KTRs take could inhibit the development of protective ...
Aug 30, 2022
0
27
Solid organ transplants—heart, lung, liver, and kidney—are resource-intensive operations that require patients to take immunosuppressive drugs after the procedure to keep the body from rejecting the new organ.
Aug 16, 2022
0
4
Organ transplant recipients take life-long immunosuppressive drugs to prevent their bodies from mounting an immune response against the donated organ, yet a substantial number of them still reject the organs. A new study ...
Jul 14, 2022
0
29
An investigative stem cell-based therapy called PEC-Direct, designed to act as a replacement pancreas, has the potential to provide blood sugar control in patients with high-risk type 1 diabetes, suggests a clinical study ...
Jun 11, 2022
0
16